Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Activity and Safety of Regorafenib in Patients With Metastatic Soft Tissue Sarcoma Previously Treated With Anthracycline-based Chemotherapy : a Multinational, Randomized, Phase II, Placebo-controlled Trial

NCT01900743 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT01900743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01900743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Activity and Safety of Regorafenib in Patients With Metastatic Soft Tissue Sarcoma Previously Treated With Anthracycline-based Chemotherapy : a Multinational, Randomized, Phase II, Placebo-controlled Trial
Lead sponsor
Centre Oscar Lambret
Phase
Phase 2
Overall status
Completed
Start date
June 5, 2013
Completion date
September 16, 2020
Enrollment
219 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma